Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Histone Variants at the Centromere

Histone Variants at the Centromere

Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

The Ras Gene

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Perineurioma-like EMA-positive calvarial neoplasms: clinicopathological study of eight cases.

Histopathology·2026

Same author

Cutaneous Epithelioid/Pleomorphic Rhabdomyosarcoma, Melanoma in Disguise? An Immunohistochemical, Molecular, and Epigenetic Study of 13 Patients.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026

Same author

Consensus recommendations in the management of jaw (gnathic) osteosarcoma.

Cancer·2026

Same author

Corrigendum to "Non-neoplastic Orthopedic Pathology Updates: Common Problems and Pitfalls and How to Avoid Them" [Modern Pathology. 2025;38(12):100911].

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026

Same author

Practice updates: Emerging entities in bone and soft tissue pathology.

Human pathology·2025

Same author

Non-neoplastic Orthopedic Pathology Updates: Common Problems and Pitfalls and How to Avoid Them.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2025

Same journal

Molecular Pathology in Contemporary Surgical Practice.

Surgical pathology clinics·2026

Same journal

Beyond Blood: Liquid biopsy assays for nonplasma body fluids.

Surgical pathology clinics·2026

Same journal

The Molecular Landscape of Ovarian Neoplasms: A Review.

Surgical pathology clinics·2026

Same journal

Clinically Relevant Molecular Pathology of Endometrial Cancer.

Surgical pathology clinics·2026

Same journal

Molecular Pathology of Genitourinary Tumors: Diagnostic, Prognostic, and Therapeutic Implications.

Surgical pathology clinics·2026

Same journal

Oncogenicity and Therapeutic Implications of Molecular Biomarkers in Colorectal Carcinoma.

Surgical pathology clinics·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 26, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Chondrosarcoma Variants.

Scott E Kilpatrick¹

¹Pathologists Diagnostic Services, Forsyth Medical Center, 3333 Silas Creek Parkway, Winston-Salem, NC 27104, USA.

Surgical Pathology Clinics

|February 4, 2016

Summary

This summary is machine-generated.

This review covers rare chondrosarcoma variants lacking dominant hyaline cartilage. It details their diagnosis, imaging, pathology, and prognosis for better understanding of these uncommon bone tumors.

More Related Videos

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

Related Experiment Videos

Last Updated: Mar 26, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

Area of Science:

Orthopedic Oncology
Skeletal Pathology
Radiology

Background:

Chondrosarcoma is a malignant bone tumor arising from cartilage.
Typical chondrosarcomas exhibit hyaline cartilage features.
Rare variants deviate from this classic presentation.

Purpose of the Study:

To review and characterize rare chondrosarcoma variants.
To focus on variants where hyaline cartilage is not the dominant feature.
To aid in the differential diagnosis and management of these unusual neoplasms.

Main Methods:

Literature review of chondrosarcoma variants.
Analysis of radiologic, gross, and microscopic features.
Summarization of key diagnostic and prognostic information.

Main Results:

Detailed descriptions of rare chondrosarcoma subtypes.
Emphasis on differential diagnoses for non-hyaline cartilage-predominant tumors.
Key features distinguishing major variants are summarized.

Conclusions:

Rare chondrosarcoma variants present unique diagnostic challenges.
Accurate identification requires integrating clinical, radiologic, and histopathologic findings.
Understanding these variants improves patient management and outcomes.